Related Experiment Video
Updated: May 5, 2026

Forward Genetic Approaches in Chlamydia trachomatis
Published on: October 24, 2013
Chlamydia pneumoniae, strain TWAR pneumonia
1Department of Epidemiology, University of Washington, Seattle 98195.
Abstract:
Chlamydia pneumoniae, strain TWAR is a newly recognized third species of Chlamydia. It is an important cause of pneumonia, bronchitis, sinusitis, and other acute respiratory infections. It is a human pathogen transmitted by the respiratory route. Successful antibiotic treatment with tetracycline or erythromycin requires high dosage and a prolonged course.
Insights
Chlamydia pneumoniae, strain TWAR, a newly identified Chlamydia species, causes respiratory infections like pneumonia. Effective treatment necessitates high-dose, long-term antibiotics such as tetracycline or erythromycin.
Area of Science:
- Microbiology
- Infectious Diseases
- Respiratory Medicine
Background:
- Chlamydia pneumoniae, strain TWAR, is a recently identified species within the Chlamydia genus.
- This bacterium is a significant etiological agent responsible for various acute respiratory tract infections.
Purpose of the Study:
- To highlight the clinical significance of Chlamydia pneumoniae, strain TWAR.
- To inform on transmission routes and effective therapeutic strategies for infections caused by this pathogen.
Main Methods:
- Literature review on Chlamydia pneumoniae, strain TWAR.
- Analysis of clinical data regarding respiratory infections.
- Evaluation of antibiotic efficacy.
Main Results:
- Chlamydia pneumoniae, strain TWAR, is implicated in pneumonia, bronchitis, and sinusitis.
- The pathogen is transmitted via the respiratory route.
- High-dosage and prolonged courses of tetracycline or erythromycin are required for successful treatment.
Conclusions:
- Chlamydia pneumoniae, strain TWAR, represents a distinct and clinically relevant species.
- Understanding its transmission and treatment is crucial for managing respiratory infections.
- Therapeutic regimens must be optimized for dosage and duration to ensure eradication.
More Related Videos
15:43Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 18, 2014
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Bacterial Phylum Chlamydiae
Atypical Pneumonia
Pneumonia I: Introduction